In the present study, we demonstrate the proof of concept of the autologous stem cell-based ex vivo gene correction approach for the treatment of MPS-1 by using the disease model animal, Idua knockout (KO) mice [10]. Here, IDUA is linked to mucopolysaccharidosis type 1.